StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
688500.SS$55.72+7.75%
Fair $55.72+0.0%

688500.SS

HCR Co., Ltd

Technology / Information Technology ServicesShanghai

$55.72

+4.01 (+7.75%)

Fairly Valued+0.0%Fair Value $55.72Fund rank 27/100 · Data gapFallback financials|
SA 31/D
F-Score: 6/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 19%

FCF escenarios

weak_data · normalized FCF $-28.8M · quality 47.3/100

Data gap 27/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 16/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

31/100

D

Piotroski

6/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. ROE is -5.4%, below the 5% threshold
Thesis & Journal · 688500.SSLocal privado en este navegador · HCR Co., Ltd
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$4.2B

P/E

N/A

•

EV/EBITDA

N/A

•

ROE

-5.4%

↓

Gross Margin

26.4%

↓

Debt/Equity

0.01

↓
52-Week Range$56
$29$91

TradingView lightweight chart

688500.SS price, volumen y niveles de valoración

Último $55.72Periodo -48.9%
Fair value: $55.72

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+0.5%

FCF CAGR

—

FCF margin

4.5%

FCF / Net income

-0.58x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $505.0M · net income $-39.8M · FCF $22.9M

2022-FY → 2025-FY

Gross margin

26.4%-1.5% pts

Operating margin

-8.4%+0.3% pts

Net margin

-7.9%+9.5% pts

FCF margin

4.5%+11.2% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$505.0M$505.0M$444.0M$539.4M$498.2M
Net Income$-39.8M$-39.8M$-53.4M$-169.8M$-86.7M
EBITDA$-18.5M$-18.5M$-21.1M$-171.2M$-86.1M
EPS-0.55-0.55-0.73-2.31-1.17
Gross Margin26.4%26.4%31.1%31.4%27.9%
Operating Margin-8.4%-8.4%-12.0%-10.5%-8.7%
Net Margin-7.9%-7.9%-12.0%-31.5%-17.4%
Balance Sheet
Debt/Equity0.010.010.020.040.02
Current Ratio3.913.91———
Cash Flow
Free Cash Flow$22.9M$22.9M$-74.0M$-28.8M$-33.1M
Returns
ROE-5.4%-5.4%-7.2%-21.4%-8.9%
Valuation
P/B5.515.513.382.361.73
Growth & Yield
Revenue Growth13.7%13.7%-17.7%8.3%—
EPS Growth24.7%24.7%68.4%-97.8%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +71.6%

Total return

+71.6%

Start / end P/E

n/dx → n/dx

EPS bridge

-0.73 → -0.55

Residual

+71.6%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term+71.6%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.